Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Plos One|August 9, 2014
Systemic CD8+ T cell-mediated tumoricidal effects by intratumoral treatment of oncolytic herpes simplex virus with the agonistic monoclonal antibody for murine glucocorticoid-induced tumor necrosis factor receptorMikiya Ishihara, Naohiro Seo, Jun Mitsui, et al.
Plos One|June 9, 2016
A Functionally Superior Second-Generation Vector Expressing an Aurora Kinase-A-Specific T-Cell Receptor for Anti-Leukaemia Adoptive ImmunotherapyNicholas Paul Casey, Hiroshi Fujiwara, Kazushi Tanimoto, et al.
Plos One|August 23, 2011
In vivo safety and persistence of endoribonuclease gene-transduced CD4+ T cells in cynomolgus macaques for HIV-1 gene therapy modelHideto Chono, Naoki Saito, Hiroshi Tsuda, et al.
Molecular Therapy. Nucleic Acids|December 20, 2012
A Promising Vector for TCR Gene Therapy: Differential Effect of siRNA, 2A Peptide, and Disulfide Bond on the Introduced TCR ExpressionSachiko Okamoto, Yasunori Amaishi, Yumi Goto, et al.
Molecular Therapy Oncolytics|January 22, 2019
Functional Analysis of an Inducible Promoter Driven by Activation Signals from a Chimeric Antigen ReceptorRyosuke Uchibori, Takeshi Teruya, Hiroyuki Ido, et al.
Human Gene Therapy Methods|February 28, 2013
Sustained inhibition of HIV-1 replication by conditional expression of the E. coli-derived endoribonuclease MazF in CD4+ T cellsMika Okamoto, Hideto Chono, Yasuhiro Kawano, et al.
Oncoimmunology|October 21, 2016
Efficient tumor regression by adoptively transferred CEA-specific CAR-T cells associated with symptoms of mild cytokine release syndromeLinan Wang, Ning Ma, Sachiko Okamoto, et al.
Blood|June 16, 2011
Novel adoptive T-cell immunotherapy using a WT1-specific TCR vector encoding silencers for endogenous TCRs shows marked antileukemia reactivity and safetyToshiki Ochi, Hiroshi Fujiwara, Sachiko Okamoto, et al.
Nucleic Acids Research|April 4, 2006
The expression profile of microRNAs in mouse embryosJunichi Mineno, Sachiko Okamoto, Tatsuya Ando, et al.
Scientific Reports|October 9, 2015
Direct tumor recognition by a human CD4(+) T-cell subset potently mediates tumor growth inhibition and orchestrates anti-tumor immune responsesJunko Matsuzaki, Takemasa Tsuji, Immanuel F Luescher, et al.
Pageof 6